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Like the study by Hendriksen et al.,1 in which 3826 African children were enrolled during 
hospitalization for severe malaria, our birth cohort study revealed high PfHRP-2 levels 
during fatal severe malaria (4619 to 30,169 ng per milliliter), a similar mean level during 
non-fatal severe malaria (1245 ng per milliliter in our study vs. 1046 ng per milliliter in 
Hendriksen et al.), and occasionally low or undetectable levels of PfHRP-2 during severe 
malaria. We also reported higher mean PfHRP-2 levels in children with high-density 
infections and only mild symptoms than in the same children during severe malaria 
episodes, which suggests that PfHRP-2 level is an indicator of parasite biomass and the 
duration of infection rather than disease. Mean parasite density and PfHRP-2 level are 
generally higher during severe malaria, but there is considerable overlap of PfHRP-2 values 
in severe and uncomplicated cases of malaria,2-4 an observation that has been reported in 
studies that incorporate retinal findings.5 Severe malaria with very low or undetectable levels 
of PfHRP-2 has often been reported.2-4 Our findings and earlier obser-vations2,3 suggest that 
factors in addition to total parasite biomass may contribute to malaria severity, including 
organ-specific parasite burden, local or systemic immunopathology, and parasite virulence. 
Our study also shows that immunity to severe malaria develops long before immunity that 
controls parasite burden.
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